Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema

Diabetic retinopathy (DR) is the most common cause of visual loss among working age individuals. Diabetic macular edema (DME) is an important complication of DR that affects around one third of the patients with DR. Several treatments have been approved for DME ranging from blood pressure and glycem...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Moradi, Ahmadreza, Sepah, Yasir Jamal, Sadiq, Mohammad Ali, Nasir, Humzah, Kherani, Salima, Sophie, Raafay, Do, Diana V, Nguyen, Quan Dong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Co., Limited 2013
Gaiak:
Topic Highlight
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874490/
https://ncbi.nlm.nih.gov/pubmed/24379921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i6.303
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak